Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Dec;35(12):2602–2605. doi: 10.1128/aac.35.12.2602

Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery.

C Martin 1, B Sastre 1, M N Mallet 1, B Bruguerolle 1, J P Brun 1, P De Micco 1, F Gouin 1
PMCID: PMC245438  PMID: 1810194

Abstract

The levels of metronidazole in serum and tissue penetration of metronidazole were studied after prophylactic administration in 11 patients undergoing elective colorectal surgery. A single dose of 1,000 mg given intravenously was administered before surgery. Adequate drug levels in serum (greater than or equal to MIC for 90% of strains tested [MIC90] for Bacteroides fragilis) were found in all patients throughout the procedure. Mean peak (15-min) and last-determined (24-h) metronidazole levels in serum were 28.8 +/- 8 and 4.2 +/- 1.7 mg/liter, respectively. The beta-phase elimination half-life was 9.5 +/- 2.3 h, and the clearance and apparent volume of distribution were 57 +/- 13 ml/min and 0.7 +/- 0.1 liter/kg, respectively. In the colonic wall at surgical anastomosis, tissue metronidazole levels greater than or equal to MIC90 for B. fragilis were found in 91% of patients. In the abdominal wall fat and epiploic fat, tissue metronidazole levels greater than or equal to MIC90 for B. fragilis were found in 40 to 60% of patients at surgical incision and closure. No anaerobic infection occurred during the study.

Full text

PDF
2605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M. L., Anish D. S., Chalmers T. C., Sacks H. S., Smith H., Jr, Fagerstrom R. M. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med. 1981 Oct 1;305(14):795–799. doi: 10.1056/NEJM198110013051404. [DOI] [PubMed] [Google Scholar]
  2. Bergamini T. M., Polk H. C., Jr The importance of tissue antibiotic activity in the prevention of operative wound infection. J Antimicrob Chemother. 1989 Mar;23(3):301–313. doi: 10.1093/jac/23.3.301. [DOI] [PubMed] [Google Scholar]
  3. Brass C., Richards G. K., Ruedy J., Prentis J., Hinchey E. J. The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery. Am J Surg. 1978 Jan;135(1):91–96. doi: 10.1016/0002-9610(78)90016-8. [DOI] [PubMed] [Google Scholar]
  4. Burke J. F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961 Jul;50:161–168. [PubMed] [Google Scholar]
  5. DiPiro J. T., Cheung R. P., Bowden T. A., Jr, Mansberger J. A. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg. 1986 Nov;152(5):552–559. doi: 10.1016/0002-9610(86)90228-x. [DOI] [PubMed] [Google Scholar]
  6. Eykyn S. J., Jackson B. T., Lockhart-Mummery H. E., Phillips I. Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet. 1979 Oct 13;2(8146):761–764. doi: 10.1016/s0140-6736(79)92114-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hunt P. S., Francis J. K., Peck G., Farrell K., Sali A. Tinidazole in the prevention of wound infection after elective colorectal surgery. Med J Aust. 1979 Feb 24;1(4):107–109. doi: 10.5694/j.1326-5377.1979.tb112039.x. [DOI] [PubMed] [Google Scholar]
  8. Kaiser A. B. Antimicrobial prophylaxis in surgery. N Engl J Med. 1986 Oct 30;315(18):1129–1138. doi: 10.1056/NEJM198610303151805. [DOI] [PubMed] [Google Scholar]
  9. Keighley M. R., Arabi Y., Alexander-Williams J., Youngs D., Burdon D. W. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979 Apr 28;1(8122):894–897. doi: 10.1016/s0140-6736(79)91373-4. [DOI] [PubMed] [Google Scholar]
  10. Kling P. A., Holmlund D., Burman L. G. Single-dose intravenous metronidazole v. doxycycline prophylaxis in colorectal surgery. An open prospective, randomized trial. Acta Chir Scand. 1985;151(2):163–168. [PubMed] [Google Scholar]
  11. Kosmidis J., Stathakis C., Mantopoulos K., Pouriezi T., Papathanassiou B., Daikos G. K. Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):147–151. doi: 10.1093/jac/6.suppl_a.147. [DOI] [PubMed] [Google Scholar]
  12. Lorian V. Low concentrations of antibiotics. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):15–26. doi: 10.1093/jac/15.suppl_a.15. [DOI] [PubMed] [Google Scholar]
  13. Martin C., Bruguerolle B., Mallet M. N., Condomines M., Sastre B., Gouin F. Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery. Antimicrob Agents Chemother. 1990 Oct;34(10):1921–1924. doi: 10.1128/aac.34.10.1921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mitchell N. J., Evans D. S., Pollock D. Single dose metronidazole with and without cefuroxime in elective colorectal surgery. Br J Surg. 1983 Nov;70(11):668–669. doi: 10.1002/bjs.1800701109. [DOI] [PubMed] [Google Scholar]
  15. Mittermayer H., Gross C., Brücke P. Single dose cefuroxime/metronidazole versus metronidazole alone in elective colorectal surgery. Am Surg. 1984 Aug;50(8):418–423. [PubMed] [Google Scholar]
  16. Mutch D., Richards G., Brown R. A., Mulder D. S. Bioactive antibiotic levels in the human aorta. Surgery. 1982 Dec;92(6):1068–1071. [PubMed] [Google Scholar]
  17. Pitt H. A., Roberts R. B., Johnson W. D., Jr Gentamicin levels in the human biliary tract. J Infect Dis. 1973 Mar;127(3):299–302. doi: 10.1093/infdis/127.3.299. [DOI] [PubMed] [Google Scholar]
  18. Polk H. C., Jr, Lopez-Mayor J. F. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery. 1969 Jul;66(1):97–103. [PubMed] [Google Scholar]
  19. Ralph E. D. Clinical pharmacokinetics of metronidazole. Clin Pharmacokinet. 1983 Jan-Feb;8(1):43–62. doi: 10.2165/00003088-198308010-00003. [DOI] [PubMed] [Google Scholar]
  20. Tally F. P., Cuchural G. J., Jr, Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother. 1985 Nov;28(5):675–677. doi: 10.1128/aac.28.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Washington J. A., 2nd The effects and significance of subminimal inhibitory concentrations of antibiotics. Rev Infect Dis. 1979 Sep-Oct;1(5):781–786. doi: 10.1093/clinids/1.5.781. [DOI] [PubMed] [Google Scholar]
  22. Zak O., Kradolfer F. Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis. 1979 Sep-Oct;1(5):862–879. doi: 10.1093/clinids/1.5.862. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES